PTC Therapeutics | PTCT - Interest Expense On Debt



PTC Therapeutics reported $30.36M in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
Acadia Pharmaceuticals 0 4.12M Sep/2024
Alnylam Pharmaceuticals USD 40.25M 1.6M Jun/2025
Amgen USD 694M 29M Jun/2025
Biogen USD 72.6M 12.6M Jun/2025
BioMarin Pharmaceutical USD 2.68M 184K Jun/2025
Cytokinetics USD 24.26M 1.32M Jun/2025
Daiichi Sankyo 1.42B 5.66B Jun/2025
Gilead Sciences USD 254M 6M Jun/2025
Incyte USD 594K 66K Jun/2025
Ionis Pharmaceuticals USD 19M 0 Jun/2025
Ironwood Pharmaceuticals USD 8.74M 506K Dec/2024
Novartis USD 289M 19M Jun/2025
Pfizer USD 654M 0 Jun/2025
PTC Therapeutics USD 30.36M 4.03M Jun/2025
Roche Holding CHF 311.5M 1000K Dec/2024
Sarepta Therapeutics USD 5.23M 725K Jun/2025
TG Therapeutics USD 6.72M 4.12M Jun/2025
Ultragenyx Pharmaceutical 14.04M 1.48M Jun/2025
Vertex Pharmaceuticals USD 3.7M 900K Jun/2025
Xencor 8.24M 422K Jun/2025